Regeneron weighs overseas price for Otarmeni, gene therapy for rare type of hearing loss
Summary
Regeneron will make its newly approved gene therapy available for free in the U.S. The company hasn't yet decided how much it will charge in other countries.
Description
Regeneron will make its newly approved gene therapy available for free in the U.S. The company hasn't yet decided how much it will charge in other countries.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source